Business Segments and Geographic Areas

12 Months Ended

Dec. 31, 2012

Segment Reporting [Abstract]

Business Segments and Geographic Areas

Business Segments and Geographic Areas

CONMED conducts its business through five principal operating segments, CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care.  We believe each of our segments are similar in the nature of products, production processes, customer base, distribution methods and regulatory environment.  Our CONMED Endosurgery, CONMED Electrosurgery and CONMED Linvatec operating segments also have similar economic characteristics and therefore qualify for aggregation.  Our CONMED Patient Care and CONMED Endoscopic Technologies operating segments do not qualify for aggregation since their economic characteristics do not meet the criteria for aggregation as a result of the lower overall operating income (loss) in these segments.

CONMED Endosurgery, CONMED Electrosurgery and CONMED Linvatec consist of a single aggregated reportable segment comprising a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic procedures, electrosurgical generators and related surgical instruments, arthroscopic instrumentation for use in orthopedic surgery and small bone, large bone and specialty powered surgical instruments.  CONMED Patient Care product offerings include a line of vital signs and cardiac monitoring products as well as suction instruments & tubing for use in the operating room.  CONMED Endoscopic Technologies product offerings include a comprehensive line of minimally invasive endoscopic diagnostic and therapeutic instruments used in procedures which require examination of the digestive tract.

The following is net sales information by product line and reportable segment:

	2010		2011		2012
Arthroscopy	$	288,421	$	289,878	$	330,567
Powered Surgical Instruments	142,288		147,849		149,968
CONMED Linvatec	430,709		437,727		480,535
CONMED Electrosurgery	97,210		98,632		95,743
CONMED Endosurgery	69,004		73,716		73,995
CONMED Linvatec, Electrosurgery,
and Endosurgery	596,923		610,075		650,273
CONMED Patient Care	68,283		65,651		63,697
CONMED Endoscopic Technologies	48,517		49,351		53,170
Total	$	713,723	$	725,077	$	767,140

Total assets, capital expenditures, depreciation and amortization information are impracticable to present by reportable segment because the necessary information is not available.

The following is a reconciliation between segment operating income (loss) and income (loss) before income taxes.  The Corporate line includes corporate related items not allocated to reportable segments:

	2010			2011			2012
CONMED Linvatec, Electrosurgery
and Endosurgery	$	77,271		$	89,093		$	81,848
CONMED Patient Care	(38		)	(62,878		)	(2,210		)
CONMED Endoscopic Technologies	(1,315		)	273			2,738
Corporate	(18,825		)	(18,214		)	(17,166		)
Income from operations	57,093			8,274			65,210
Loss on early extinguishment of debt	79			—			—
Amortization of debt discount	4,244			3,903			—
Interest expense	7,113			6,676			5,730
Income (loss) before income taxes	$	45,657		$	(2,305	)	$	59,480

Net sales information for geographic areas consists of the following:

	2010		2011		2012
United States	$	371,914	$	364,588	$	382,256
Canada	61,593		65,794		73,746
United Kingdom	31,576		32,106		31,653
Japan	32,226		34,178		33,997
Australia	34,564		40,122		40,835
All other countries	181,850		188,289		204,653
Total	$	713,723	$	725,077	$	767,140

Sales are attributed to countries based on the location of the customer. There were no significant investments in long-lived assets located outside the United States at December 31, 2011 and 2012.  No single customer represented over 10% of our consolidated net sales for the years ended December 31, 2010, 2011 and 2012.